Pain 101 Q&A

Potent Pearls

Doug Gourlay, MD, FRCPC, FASAM, Howard A. Heit, MD, FACP, FASAM

Pain 101 Q&A published on August 15, 2008 in Assess & Monitor

Drs. Heit and Gourlay answer questions from the audience regarding benzodiazepine withdrawal and abuse potential of fentanyl transdermal patches.

Doug Gourlay, MD, FRCPC, FASAM, Howard A. Heit, MD, FACP, FASAM

Pain 101 Q&A published on July 18, 2008 in Misuse

Dr. Gourlay answers questions regarding third-party information, interpreting urine drug test results, and setting boundaries for the prescription of controlled substances.

Rules of Engagement

Doug Gourlay, MD, FRCPC, FASAM, Howard A. Heit, MD, FACP, FASAM

Pain 101 Q&A published on June 20, 2008 in Assess & Monitor

Dr. Heit responds to questions on 'Do Not Fill' regulations, detoxification vs. tapering, and sequential prescriptions. He also discusses Schedule II prescribing regulations and documentation.

Steven P. Stanos, DO, Howard A. Heit, MD, FACP, FASAM

Pain 101 Q&A published on May 16, 2008 in Assess & Monitor

Dr. Stanos discusses a comprehensive program for pain management that emphasizes activity, strength, and educating patients about biofeedback.

Brian Ginsberg, MD, Howard A. Heit, MD, FACP, FASAM

Pain 101 Q&A published on April 21, 2008 in Assess & Monitor

Dr. Ginsberg addresses the effects of methadone on the heart, the role of pharmacists in pain management, and mortality associated with pharmacotherapy.

Peggy Compton, RN, PhD, FAAN, Howard A. Heit, MD, FACP, FASAM

Pain 101 Q&A published on March 31, 2008 in Assess & Monitor

Dr. Compton answers complex questions about chronic opioid therapy and other pain and addiction management issues based on neurobiologic evidence.